Concentric Analgesics

company

About

Concentric Analgesics is a biotechnology company that develops non-opioid therapeutics for the management of acute and chronic pain.

  • San Francisco,California,United States
  • 11 - 50

Details

Last Funding Type
Convertable Note
Last Funding Money Raised
$20M
Industries
Biotechnology,Health Care,Medical,Medical Device
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Concentric Analgesics, Inc.

Concentric Analgesics is developing a portfolio of novel, non-opioid therapeutics that provide pain relief after a single local administration. It is a biotechnology company focused on developing non-opioid therapeutics for the management of acute and chronic pain.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$103.07M
Concentric Analgesics has raised a total of $103.07M in funding over 2 rounds. Their latest funding was raised on Jan 26, 2022 from a Convertable Note round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 26, 2022 Convertable Note $20M Detail
May 22, 2019 Series B $77.10M 3 Oracle Investment Management Inc. Detail
Aug 17, 2016 Series Unknown $5.97M Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Concentric Analgesics is funded by 3 investors. Oracle Investment Management Inc. and Cowen Healthcare Investments are the most recent investors.
Investor Name Lead Investor Funding Round
Oracle Investment Management Inc. Yes Series B
Cowen Healthcare Investments Series B
Venrock Series B

Employee Profiles

Number of Employee Profiles
7
Concentric Analgesics has 7 current employee profiles, including Executive Frank J. Bellizzi
Executive
Executive
Executive
Board member
Executive